Header cover image

South Korean (KOSPI) Healthcare Sector Analysis

UpdatedJan 19, 2022
DataAggregated Company Financials
Companies319
  • 7D-9.3%
  • 3M-13.8%
  • 1Y-27.2%
  • YTD-13.0%

Over the last 7 days, the Healthcare industry has dropped 9.3%, driven by a pullback from Celltrion of 15%. Meanwhile, ABL Bio actually outperformed within the industry, gaining 23% in the last week. However, the industry is down 27% over the past year.

Sector Valuation and Performance

Has the South Korean Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Thu, 20 Jan 2022₩231.4t₩49.0t₩4.3t21.7x
Sat, 18 Dec 2021₩272.8t₩49.0t₩4.3t25.3x
Mon, 15 Nov 2021₩256.1t₩48.0t₩4.3t21.9x
Wed, 13 Oct 2021₩258.7t₩48.0t₩4.3t22.4x
Fri, 10 Sep 2021₩304.3t₩49.5t₩4.3t28x
Sun, 08 Aug 2021₩306.1t₩48.8t₩4.2t29.1x
Sat, 01 May 2021₩273.2t₩44.3t₩2.9t26.2x
Tue, 02 Feb 2021₩274.9t₩42.7t₩2.2t26.6x
Fri, 06 Nov 2020₩230.5t₩41.1t₩1.6t27.5x
Mon, 10 Aug 2020₩242.6t₩39.3t₩1.0t32.8x
Sun, 03 May 2020₩165.6t₩37.7t₩855.3b24.9x
Wed, 05 Feb 2020₩140.4t₩36.6t₩803.2b26.9x
Sat, 09 Nov 2019₩140.2t₩34.3t₩856.9b22.3x
Fri, 02 Aug 2019₩125.9t₩33.3t₩925.4b25.8x
Mon, 06 May 2019₩162.8t₩32.5t₩923.2b34.7x
Thu, 07 Feb 2019₩164.4t₩31.7t₩956.7b33.7x
PE Ratio

33.7x

Total Market Cap: ₩164.4tTotal Earnings: ₩956.7bTotal Revenue: ₩31.7t0%0%0%3 Year10 Year
202020212022

Current Industry PE: Investors are more pessimistic on the industry, considering it's trading at a PE ratio of 21.7x which is lower than its 3-year average PE of 27.7x. It appears they believe that earnings will not grow as fast as they have historically.

Past Earnings Growth: The earnings for companies in the Healthcare industry have grown 65% per year over the last three years, and revenues for these companies have grown 16% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the South Korean Healthcare sector?

Medical Equipment-4.71%
Life Sciences-6.12%
Pharma-7.62%
Healthtech-7.81%
Biotech-12.30%
Healthcare Services-17.72%

Industry PE: Investors are most optimistic about the Healthtech industry, which is trading close to its 3-year average PE ratio of 34.5x. It looks like they are confident that earnings will grow faster in the future than they have historically. Meanwhile, investors are most pessimistic about the Healthcare Services industry, which is trading below its 3-year average of 80.9x.

Forecasted Growth: Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 28% over the next 5 years. This is better than its past earnings decline of 18% per year. Meanwhile, the Medical Equipment industry is expected to see its earnings decline by 2.6% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A298380 ABL Bio₩32.10k18.0%
+₩230.9b
21.8%PS150.9x
A142760 Bioleaders₩12.05k46.1%
+₩108.9b
102.5%PS3.5x
A137310 SD BioSensor₩51.40k1.0%
+₩51.3b
n/aPE4.2x
A294090 EOFLOWLtd₩25.85k6.5%
+₩36.4b
-32.3%PS1270.5x
A241820 PCL₩41.00k4.6%
+₩18.7b
31.6%PS9.9x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News